Related Experiment Video
Updated: Jun 17, 2026

09:05
Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice
Published on: May 4, 2015
Myocardial infarction in the young
1Department of Cardiology, Gazi University, Faculty of Medicine, Besevler, Ankara, Turkey.
Journal of Postgraduate Medicine
|January 20, 2010
Summary
Younger adults are increasingly hospitalized for acute myocardial infarction due to atherosclerosis risk factors. Non-atherosclerotic causes and hypercoagulability also warrant investigation in these patients.
Area of Science:
- Cardiology
- Vascular Medicine
- Preventive Cardiology
Background:
- Rising incidence of acute myocardial infarction (AMI) in patients under 40.
- Increased prevalence of traditional atherosclerosis risk factors in younger populations, including impaired fasting glucose, dyslipidemia (high triglycerides, low HDL), and central obesity (waist-to-hip ratio).
Purpose of the Study:
- To review the pathophysiology of acute coronary syndromes in young patients.
- To discuss diagnostic and therapeutic options for non-atherosclerotic causes of AMI in youth.
- To highlight the importance of considering hypercoagulable states and non-atherosclerotic coronary artery disease in younger AMI patients.
Main Methods:
- Literature review using PubMed.
- Search terms included: premature atherosclerosis, hypercoagulable states, risk factors for atherosclerosis in youth, novel risk factors for atherosclerosis, non-atherosclerotic coronary artery diseases.
Main Results:
- Younger patients hospitalized for AMI often present with increased prevalence of atherosclerosis risk factors.
- Non-atherosclerotic conditions and hypercoagulability are crucial differential diagnoses in this demographic.
- Pathophysiology, diagnostics, and therapeutics for various causes of AMI in young individuals were reviewed.
Conclusions:
- While traditional risk factors contribute to AMI in young adults, a broader differential diagnosis is essential.
- Investigation into non-atherosclerotic coronary artery disease and hypercoagulable states should be considered in younger patients presenting with acute coronary syndromes.
- Comprehensive evaluation is necessary for effective management and prevention strategies in youth experiencing AMI.
Related Concept Videos
Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

